Security Snapshot

Journey Medical Corp - COM (DERM) Institutional Ownership

CUSIP: 48115J109

13F Institutional Holders and Ownership History from Q4 2021 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

76

Shares (Excl. Options)

11,022,797

Price

$7.71

Type / Class
Equity / COM
Symbol
DERM on Nasdaq
Shares outstanding
21,333,700
Price per share
$4.69
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
11,022,797
Total reported value
$84,985,269
% of total 13F portfolios
0%
Share change
+2,437,780
Value change
+$18,818,454
Number of holders
76
Price from insider filings
$4.69
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • DERM - Journey Medical Corp - COM is tracked under CUSIP 48115J109.
  • 76 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 76 to 1 between Q4 2025 and Q1 2026.
  • Reported value moved from $84,985,269 to $474.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Official SEC Source

Backed by Form 13F

Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.

See Original Filing

Investment Quick Answers

What is CUSIP 48115J109?
CUSIP 48115J109 identifies DERM - Journey Medical Corp - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Journey Medical Corp - COM (DERM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WASATCH ADVISORS LP 10% +47% $16,554,951 +$7,614,973 2,133,370 +85% Wasatch Advisors LP 31 Mar 2026
TANG CAPITAL MANAGEMENT LLC 8% $14,020,746 1,854,596 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025

As of 31 Dec 2025, 76 institutional investors reported holding 11,022,797 shares of Journey Medical Corp - COM (DERM). This represents 52% of the company’s total 21,333,700 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Journey Medical Corp - COM (DERM) together control 48% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
TANG CAPITAL MANAGEMENT LLC 8.7% 1,854,596 0% 0.71% $14,298,935
WASATCH ADVISORS LP 6.2% 1,316,275 +0.77% 0.06% $10,148,480
Opaleye Management Inc. 4.6% 975,000 +0.41% 1% $7,517,250
J. Goldman & Co LP 3.7% 798,366 0.24% $6,155,402
VANGUARD GROUP INC 3.6% 764,147 +24% 0% $5,891,574
BlackRock, Inc. 3.4% 719,784 +14% 0% $5,549,535
MILLENNIUM MANAGEMENT LLC 2.1% 457,812 0% $3,529,731
Pale Fire Capital SE 2.1% 444,642 +95% 0.44% $3,428,190
Summit Financial, LLC 1.8% 390,419 +2.8% 0.04% $3,010,130
ESSEX INVESTMENT MANAGEMENT CO LLC 1.6% 345,977 -2.3% 0.41% $2,667,483
GEODE CAPITAL MANAGEMENT, LLC 1.5% 313,970 +13% 0% $2,420,885
UBS Group AG 1.4% 290,226 +100% 0% $2,237,642
Ikarian Capital, LLC 1.2% 251,436 0.25% $1,938,572
RENAISSANCE TECHNOLOGIES LLC 1.1% 244,000 -1.6% 0% $1,881,240
AMERICAN FINANCIAL GROUP INC 0.84% 180,000 0% 0.5% $1,387,800
STATE STREET CORP 0.81% 173,337 +19% 0% $1,336,428
Legato Capital Management LLC 0.52% 111,695 +9.6% 0.07% $861,168
SEI INVESTMENTS CO 0.51% 109,351 0% $843,096
NORTHERN TRUST CORP 0.44% 93,669 +1% 0% $722,188
Informed Momentum Co LLC 0.42% 89,389 0% 0.08% $689,189
CITADEL ADVISORS LLC 0.33% 69,415 +382% 0% $535,189
BOOTHBAY FUND MANAGEMENT, LLC 0.32% 67,442 0.01% $519,978
Geneos Wealth Management Inc. 0.3% 63,280 0% 0.01% $487,889
LAZARD ASSET MANAGEMENT LLC 0.29% 62,525 0% $482,068
Diametric Capital, LP 0.24% 51,683 0.11% $398,475

Institutional Holders of Journey Medical Corp - COM (DERM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 101 $474 -$380 $4.69 1
2025 Q4 11,022,797 $84,985,269 +$18,818,454 $7.71 76
2025 Q3 8,692,790 $61,930,042 +$15,659,236 $7.12 67
2025 Q2 6,494,302 $46,629,314 +$11,145,137 $7.18 56
2025 Q1 5,017,760 $29,603,817 +$7,390,927 $5.90 38
2024 Q4 3,813,405 $14,909,751 +$6,149,987 $3.91 38
2024 Q3 2,156,982 $12,186,357 -$1,194,242 $5.65 36
2024 Q2 2,360,259 $13,310,203 +$3,384,583 $5.64 35
2024 Q1 1,816,385 $6,678,973 +$973,921 $3.68 31
2023 Q4 1,341,390 $7,982,763 -$492,957 $5.76 34
2023 Q3 2,135,266 $5,850,655 +$1,401,524 $2.74 20
2023 Q2 1,652,825 $2,627,537 -$24,753 $1.59 19
2023 Q1 1,668,350 $2,620,320 -$179,207 $1.57 16
2022 Q4 2,672,478 $5,131,893 -$313,986 $1.92 18
2022 Q3 1,878,524 $4,621,000 +$328,580 $2.46 18
2022 Q2 1,759,431 $6,580,100 +$289,703 $3.74 12
2022 Q1 1,644,289 $7,940,000 +$35,914 $4.83 13
2021 Q4 1,627,492 $8,756,000 +$8,756,000 $5.38 14

Sponsored